TYRA
Tyra Biosciences, Inc.
+0.16 (+0.65%)24.51USD138K成交股數1.5B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 39.2M | 33.5M | 25.5M | 24.3M | 25.0M | 22.2M | 22.7M | 18.0M | 17.2M | 19.3M | 12.2M | 10.4M |
| 銷售管理費用 | 9.8M | 8.5M | 7.5M | 7.1M | 6.9M | 7.5M | 5.9M | 5.5M | 5.1M | 0.00 | 0.00 | 3.9M |
| 營業利益 | −49.0M+54% | −42.0M+41% | −32.9M+15% | −31.5M+34% | −31.9M+43% | −29.7M+24% | −28.6M+79% | −23.5M+64% | −22.3M | −24.0M | −16.0M | −14.3M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −45.6M+62% | −39.3M+54% | −29.9M+24% | −28.1M+50% | −28.1M+55% | −25.6M+21% | −24.0M+81% | −18.7M+57% | −18.2M | −21.2M | −13.3M | −11.9M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.69+47% | -0.64+49% | -0.50+22% | -0.47+47% | -0.47+34% | -0.43-12% | -0.41+32% | -0.32+14% | -0.35 | -0.49 | -0.31 | -0.28 |
| 稀釋股數 | 66.0M | 61.7M | 59.7M | 59.6M | 59.3M | 57.2M | 58.9M | 58.7M | 52.2M | 42.9M | 42.6M | 42.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 73.8M | 85.0M | 62.0M | 98.5M | 101M | 92.0M | 104M | 99.5M | 254M | 216M | 232M | 242M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 383M | 412M | 302M | 321M | 343M | 364M | 381M | 392M | 405M | 238M | 250M | 255M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 29.7M | 24.5M | 21.3M | 19.4M | 19.9M | 20.4M | 18.3M | 16.4M | 14.9M | 16.2M | 11.4M | 6.3M |
| 股東權益 | 354M | 388M | 281M | 302M | 324M | 343M | 362M | 376M | 390M | 222M | 239M | 249M |
| 負債比 | 7.7% | 5.9% | 7.1% | 6.0% | 5.8% | 5.6% | 4.8% | 4.2% | 3.7% | 6.8% | 4.6% | 2.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −32.6M | – | – | −25.5M+16% | – | – | – | −22.0M | – | – | −9.8M |
| 資本支出 | – | 88K | – | – | 14K | – | – | – | 136K | – | – | 41K |
| 自由現金流 | – | −32.7M | – | – | −25.5M+15% | – | – | – | −22.2M | – | – | −9.9M |
| 折舊攤銷 | – | 138K | – | – | 143K | – | – | – | 122K | – | – | 83K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −120M | –% | -2.01 | −95.3M |
| FY2024 | – | – | −86.5M | –% | -1.51 | −70.4M |
| FY2023 | – | – | −69.1M | –% | -1.62 | −50.9M |
| FY2022 | – | – | −55.3M | –% | -1.32 | −50.8M |
| FY2021 | – | – | −26.3M | –% | -1.91 | −24.4M |
| FY2020 | – | – | −9.3M | –% | -6.05 | −8.1M |